One-Year Outcome of 49-Channel Suprachoroidal-Transretinal Stimulation Prosthesis in Patients With Advanced Retinitis Pigmentosa

To determine the feasibility of a 49-channel suprachoroidal-transretinal stimulation (STS) retinal prosthesis that was implanted for 1 year. Three patients with advanced retinitis pigmentosa (RP) and with less than or equal to hand motion (HM) vision were studied. A 49-channel STS system was implant...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Investigative ophthalmology & visual science 2016-11, Vol.57 (14), p.6147-6157
Hauptverfasser: Fujikado, Takashi, Kamei, Motohiro, Sakaguchi, Hirokazu, Kanda, Hiroyuki, Endo, Takao, Hirota, Masakazu, Morimoto, Takeshi, Nishida, Kentaro, Kishima, Haruhiko, Terasawa, Yasuo, Oosawa, Koji, Ozawa, Motoki, Nishida, Kohji
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 6157
container_issue 14
container_start_page 6147
container_title Investigative ophthalmology & visual science
container_volume 57
creator Fujikado, Takashi
Kamei, Motohiro
Sakaguchi, Hirokazu
Kanda, Hiroyuki
Endo, Takao
Hirota, Masakazu
Morimoto, Takeshi
Nishida, Kentaro
Kishima, Haruhiko
Terasawa, Yasuo
Oosawa, Koji
Ozawa, Motoki
Nishida, Kohji
description To determine the feasibility of a 49-channel suprachoroidal-transretinal stimulation (STS) retinal prosthesis that was implanted for 1 year. Three patients with advanced retinitis pigmentosa (RP) and with less than or equal to hand motion (HM) vision were studied. A 49-channel STS system was implanted in a scleral pocket, and the stability of the prosthesis, adverse events, and its efficacy were investigated. The electrode array was implanted in a scleral pocket located under the parafoveal area through a scleral incision at 14 mm in patient (Pt) 1, 16 mm in Pt 2, and 18 mm in Pt 3 from the sclerocorneal limbus. No complications occurred during surgery in all cases. During the follow-up period, iridocyclitis developed in Pt 2 and Pt 3, which was successfully treated with topical medications. The implanted devices continued functioning and elicited phosphenes in all cases. The results of localization tests (P < 0.05) and table tests (P < 0.05) were significantly better with the prosthesis turned on than turned off in Pt 3. The deviations of the walking tests were smaller with the prosthesis turned on than off in Pt 2 and Pt 3 at multiple times after the implantation. The 49-channel STS retinal prosthesis was able to elicit phosphenes in all patients with advanced RP for the entire 1-year experimental period without major complications. Better results on visual tasks were found in the eyes in which the electrode array was implanted closer to the fovea centralis.
doi_str_mv 10.1167/iovs.16-20367
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1839119405</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1839119405</sourcerecordid><originalsourceid>FETCH-LOGICAL-c332t-74e12ac71a3e42dadc095cd70102a73d42bf067cb2587e8afb246551402539fe3</originalsourceid><addsrcrecordid>eNpNkM1vFDEMxSMEoh9w5Ipy5JISJ5PJzrFaUUCqtBVthTiNvBkPGzSTLEmmEjf-dLJtqXqy_fyzpfcYewfyDKC1H328y2fQCiV1a1-wYzBGCWNX-uWz_oid5PxLSgWg5Gt2pKpmLMAx-7sJJH4QJr5Ziosz8TjyphPrHYZAE79e9gndLqboB5zETcKQExUfsO6Kn5cJi4-BX6WYy46yz9zXqYoUSubffdnx8-EOg6OBfzsc-lKZK_9zrkDM-Ia9GnHK9PaxnrLbi0836y_icvP56_r8UjitVRG2IVDoLKCmRg04ONkZN1gJUqHVQ6O2o2yt2yqzsrTCcaua1hhopDK6G0mfsg8Pf_cp_l4ol3722dE0YaC45B5WugPoGmkqKh5QV01Vt2O_T37G9KcH2R9C7w-h99D296FX_v3j62U70_BE_09Z_wMNv3-A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1839119405</pqid></control><display><type>article</type><title>One-Year Outcome of 49-Channel Suprachoroidal-Transretinal Stimulation Prosthesis in Patients With Advanced Retinitis Pigmentosa</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Fujikado, Takashi ; Kamei, Motohiro ; Sakaguchi, Hirokazu ; Kanda, Hiroyuki ; Endo, Takao ; Hirota, Masakazu ; Morimoto, Takeshi ; Nishida, Kentaro ; Kishima, Haruhiko ; Terasawa, Yasuo ; Oosawa, Koji ; Ozawa, Motoki ; Nishida, Kohji</creator><creatorcontrib>Fujikado, Takashi ; Kamei, Motohiro ; Sakaguchi, Hirokazu ; Kanda, Hiroyuki ; Endo, Takao ; Hirota, Masakazu ; Morimoto, Takeshi ; Nishida, Kentaro ; Kishima, Haruhiko ; Terasawa, Yasuo ; Oosawa, Koji ; Ozawa, Motoki ; Nishida, Kohji</creatorcontrib><description>To determine the feasibility of a 49-channel suprachoroidal-transretinal stimulation (STS) retinal prosthesis that was implanted for 1 year. Three patients with advanced retinitis pigmentosa (RP) and with less than or equal to hand motion (HM) vision were studied. A 49-channel STS system was implanted in a scleral pocket, and the stability of the prosthesis, adverse events, and its efficacy were investigated. The electrode array was implanted in a scleral pocket located under the parafoveal area through a scleral incision at 14 mm in patient (Pt) 1, 16 mm in Pt 2, and 18 mm in Pt 3 from the sclerocorneal limbus. No complications occurred during surgery in all cases. During the follow-up period, iridocyclitis developed in Pt 2 and Pt 3, which was successfully treated with topical medications. The implanted devices continued functioning and elicited phosphenes in all cases. The results of localization tests (P &lt; 0.05) and table tests (P &lt; 0.05) were significantly better with the prosthesis turned on than turned off in Pt 3. The deviations of the walking tests were smaller with the prosthesis turned on than off in Pt 2 and Pt 3 at multiple times after the implantation. The 49-channel STS retinal prosthesis was able to elicit phosphenes in all patients with advanced RP for the entire 1-year experimental period without major complications. Better results on visual tasks were found in the eyes in which the electrode array was implanted closer to the fovea centralis.</description><identifier>ISSN: 1552-5783</identifier><identifier>EISSN: 1552-5783</identifier><identifier>DOI: 10.1167/iovs.16-20367</identifier><identifier>PMID: 27835711</identifier><language>eng</language><publisher>United States</publisher><subject>Adult ; Aged ; Choroid - physiopathology ; Electric Stimulation - methods ; Evoked Potentials, Visual ; Feasibility Studies ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Pilot Projects ; Prospective Studies ; Retina - physiopathology ; Retinitis Pigmentosa - physiopathology ; Retinitis Pigmentosa - therapy ; Time Factors ; Treatment Outcome ; Visual Acuity ; Visual Prosthesis</subject><ispartof>Investigative ophthalmology &amp; visual science, 2016-11, Vol.57 (14), p.6147-6157</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c332t-74e12ac71a3e42dadc095cd70102a73d42bf067cb2587e8afb246551402539fe3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,860,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27835711$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fujikado, Takashi</creatorcontrib><creatorcontrib>Kamei, Motohiro</creatorcontrib><creatorcontrib>Sakaguchi, Hirokazu</creatorcontrib><creatorcontrib>Kanda, Hiroyuki</creatorcontrib><creatorcontrib>Endo, Takao</creatorcontrib><creatorcontrib>Hirota, Masakazu</creatorcontrib><creatorcontrib>Morimoto, Takeshi</creatorcontrib><creatorcontrib>Nishida, Kentaro</creatorcontrib><creatorcontrib>Kishima, Haruhiko</creatorcontrib><creatorcontrib>Terasawa, Yasuo</creatorcontrib><creatorcontrib>Oosawa, Koji</creatorcontrib><creatorcontrib>Ozawa, Motoki</creatorcontrib><creatorcontrib>Nishida, Kohji</creatorcontrib><title>One-Year Outcome of 49-Channel Suprachoroidal-Transretinal Stimulation Prosthesis in Patients With Advanced Retinitis Pigmentosa</title><title>Investigative ophthalmology &amp; visual science</title><addtitle>Invest Ophthalmol Vis Sci</addtitle><description>To determine the feasibility of a 49-channel suprachoroidal-transretinal stimulation (STS) retinal prosthesis that was implanted for 1 year. Three patients with advanced retinitis pigmentosa (RP) and with less than or equal to hand motion (HM) vision were studied. A 49-channel STS system was implanted in a scleral pocket, and the stability of the prosthesis, adverse events, and its efficacy were investigated. The electrode array was implanted in a scleral pocket located under the parafoveal area through a scleral incision at 14 mm in patient (Pt) 1, 16 mm in Pt 2, and 18 mm in Pt 3 from the sclerocorneal limbus. No complications occurred during surgery in all cases. During the follow-up period, iridocyclitis developed in Pt 2 and Pt 3, which was successfully treated with topical medications. The implanted devices continued functioning and elicited phosphenes in all cases. The results of localization tests (P &lt; 0.05) and table tests (P &lt; 0.05) were significantly better with the prosthesis turned on than turned off in Pt 3. The deviations of the walking tests were smaller with the prosthesis turned on than off in Pt 2 and Pt 3 at multiple times after the implantation. The 49-channel STS retinal prosthesis was able to elicit phosphenes in all patients with advanced RP for the entire 1-year experimental period without major complications. Better results on visual tasks were found in the eyes in which the electrode array was implanted closer to the fovea centralis.</description><subject>Adult</subject><subject>Aged</subject><subject>Choroid - physiopathology</subject><subject>Electric Stimulation - methods</subject><subject>Evoked Potentials, Visual</subject><subject>Feasibility Studies</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Pilot Projects</subject><subject>Prospective Studies</subject><subject>Retina - physiopathology</subject><subject>Retinitis Pigmentosa - physiopathology</subject><subject>Retinitis Pigmentosa - therapy</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><subject>Visual Acuity</subject><subject>Visual Prosthesis</subject><issn>1552-5783</issn><issn>1552-5783</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkM1vFDEMxSMEoh9w5Ipy5JISJ5PJzrFaUUCqtBVthTiNvBkPGzSTLEmmEjf-dLJtqXqy_fyzpfcYewfyDKC1H328y2fQCiV1a1-wYzBGCWNX-uWz_oid5PxLSgWg5Gt2pKpmLMAx-7sJJH4QJr5Ziosz8TjyphPrHYZAE79e9gndLqboB5zETcKQExUfsO6Kn5cJi4-BX6WYy46yz9zXqYoUSubffdnx8-EOg6OBfzsc-lKZK_9zrkDM-Ia9GnHK9PaxnrLbi0836y_icvP56_r8UjitVRG2IVDoLKCmRg04ONkZN1gJUqHVQ6O2o2yt2yqzsrTCcaua1hhopDK6G0mfsg8Pf_cp_l4ol3722dE0YaC45B5WugPoGmkqKh5QV01Vt2O_T37G9KcH2R9C7w-h99D296FX_v3j62U70_BE_09Z_wMNv3-A</recordid><startdate>20161101</startdate><enddate>20161101</enddate><creator>Fujikado, Takashi</creator><creator>Kamei, Motohiro</creator><creator>Sakaguchi, Hirokazu</creator><creator>Kanda, Hiroyuki</creator><creator>Endo, Takao</creator><creator>Hirota, Masakazu</creator><creator>Morimoto, Takeshi</creator><creator>Nishida, Kentaro</creator><creator>Kishima, Haruhiko</creator><creator>Terasawa, Yasuo</creator><creator>Oosawa, Koji</creator><creator>Ozawa, Motoki</creator><creator>Nishida, Kohji</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20161101</creationdate><title>One-Year Outcome of 49-Channel Suprachoroidal-Transretinal Stimulation Prosthesis in Patients With Advanced Retinitis Pigmentosa</title><author>Fujikado, Takashi ; Kamei, Motohiro ; Sakaguchi, Hirokazu ; Kanda, Hiroyuki ; Endo, Takao ; Hirota, Masakazu ; Morimoto, Takeshi ; Nishida, Kentaro ; Kishima, Haruhiko ; Terasawa, Yasuo ; Oosawa, Koji ; Ozawa, Motoki ; Nishida, Kohji</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c332t-74e12ac71a3e42dadc095cd70102a73d42bf067cb2587e8afb246551402539fe3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Choroid - physiopathology</topic><topic>Electric Stimulation - methods</topic><topic>Evoked Potentials, Visual</topic><topic>Feasibility Studies</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Pilot Projects</topic><topic>Prospective Studies</topic><topic>Retina - physiopathology</topic><topic>Retinitis Pigmentosa - physiopathology</topic><topic>Retinitis Pigmentosa - therapy</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><topic>Visual Acuity</topic><topic>Visual Prosthesis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fujikado, Takashi</creatorcontrib><creatorcontrib>Kamei, Motohiro</creatorcontrib><creatorcontrib>Sakaguchi, Hirokazu</creatorcontrib><creatorcontrib>Kanda, Hiroyuki</creatorcontrib><creatorcontrib>Endo, Takao</creatorcontrib><creatorcontrib>Hirota, Masakazu</creatorcontrib><creatorcontrib>Morimoto, Takeshi</creatorcontrib><creatorcontrib>Nishida, Kentaro</creatorcontrib><creatorcontrib>Kishima, Haruhiko</creatorcontrib><creatorcontrib>Terasawa, Yasuo</creatorcontrib><creatorcontrib>Oosawa, Koji</creatorcontrib><creatorcontrib>Ozawa, Motoki</creatorcontrib><creatorcontrib>Nishida, Kohji</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Investigative ophthalmology &amp; visual science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fujikado, Takashi</au><au>Kamei, Motohiro</au><au>Sakaguchi, Hirokazu</au><au>Kanda, Hiroyuki</au><au>Endo, Takao</au><au>Hirota, Masakazu</au><au>Morimoto, Takeshi</au><au>Nishida, Kentaro</au><au>Kishima, Haruhiko</au><au>Terasawa, Yasuo</au><au>Oosawa, Koji</au><au>Ozawa, Motoki</au><au>Nishida, Kohji</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>One-Year Outcome of 49-Channel Suprachoroidal-Transretinal Stimulation Prosthesis in Patients With Advanced Retinitis Pigmentosa</atitle><jtitle>Investigative ophthalmology &amp; visual science</jtitle><addtitle>Invest Ophthalmol Vis Sci</addtitle><date>2016-11-01</date><risdate>2016</risdate><volume>57</volume><issue>14</issue><spage>6147</spage><epage>6157</epage><pages>6147-6157</pages><issn>1552-5783</issn><eissn>1552-5783</eissn><abstract>To determine the feasibility of a 49-channel suprachoroidal-transretinal stimulation (STS) retinal prosthesis that was implanted for 1 year. Three patients with advanced retinitis pigmentosa (RP) and with less than or equal to hand motion (HM) vision were studied. A 49-channel STS system was implanted in a scleral pocket, and the stability of the prosthesis, adverse events, and its efficacy were investigated. The electrode array was implanted in a scleral pocket located under the parafoveal area through a scleral incision at 14 mm in patient (Pt) 1, 16 mm in Pt 2, and 18 mm in Pt 3 from the sclerocorneal limbus. No complications occurred during surgery in all cases. During the follow-up period, iridocyclitis developed in Pt 2 and Pt 3, which was successfully treated with topical medications. The implanted devices continued functioning and elicited phosphenes in all cases. The results of localization tests (P &lt; 0.05) and table tests (P &lt; 0.05) were significantly better with the prosthesis turned on than turned off in Pt 3. The deviations of the walking tests were smaller with the prosthesis turned on than off in Pt 2 and Pt 3 at multiple times after the implantation. The 49-channel STS retinal prosthesis was able to elicit phosphenes in all patients with advanced RP for the entire 1-year experimental period without major complications. Better results on visual tasks were found in the eyes in which the electrode array was implanted closer to the fovea centralis.</abstract><cop>United States</cop><pmid>27835711</pmid><doi>10.1167/iovs.16-20367</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1552-5783
ispartof Investigative ophthalmology & visual science, 2016-11, Vol.57 (14), p.6147-6157
issn 1552-5783
1552-5783
language eng
recordid cdi_proquest_miscellaneous_1839119405
source MEDLINE; DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Adult
Aged
Choroid - physiopathology
Electric Stimulation - methods
Evoked Potentials, Visual
Feasibility Studies
Female
Follow-Up Studies
Humans
Male
Middle Aged
Pilot Projects
Prospective Studies
Retina - physiopathology
Retinitis Pigmentosa - physiopathology
Retinitis Pigmentosa - therapy
Time Factors
Treatment Outcome
Visual Acuity
Visual Prosthesis
title One-Year Outcome of 49-Channel Suprachoroidal-Transretinal Stimulation Prosthesis in Patients With Advanced Retinitis Pigmentosa
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T01%3A58%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=One-Year%20Outcome%20of%2049-Channel%20Suprachoroidal-Transretinal%20Stimulation%20Prosthesis%20in%20Patients%20With%20Advanced%20Retinitis%20Pigmentosa&rft.jtitle=Investigative%20ophthalmology%20&%20visual%20science&rft.au=Fujikado,%20Takashi&rft.date=2016-11-01&rft.volume=57&rft.issue=14&rft.spage=6147&rft.epage=6157&rft.pages=6147-6157&rft.issn=1552-5783&rft.eissn=1552-5783&rft_id=info:doi/10.1167/iovs.16-20367&rft_dat=%3Cproquest_cross%3E1839119405%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1839119405&rft_id=info:pmid/27835711&rfr_iscdi=true